Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ezetimibe Added to Atorvastatin in Hypercholesterolemia and CHD
NCT00092625Phase 3Completed
- Sponsor
- Organon & Co.
- Start
- Mar 2003
- Primary completion
- Jul 2004
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial in hypercholesterolemia comparing Ezetimibe + Atorvastatin with Placebo + Atorvastatin (2 arms). Primary endpoint: Percentage of patients reaching their target LDL-C goal of <= 2.60 mmol/L at 6 weeks. Started Mar 2003; status: completed.
02
Drugs
ezetimibe
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT00092625.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00092625.